Saturday, November 2
Shadow

FDA Issues Emergency Use Authorization for Regeneron Monoclonal Antibody Cocktail

FDA Issues Emergency Use Authorization for Regeneron Monoclonal Antibody Cocktail

qm4o0lzsdo6g8ovlbbo2

The Food and Drug Administration on Saturday issued an emergency use authorization to Regeneron for its covid-19 monoclonal antibody cocktail, which is made up of the antibodies casirivimab and imdevimab, citing a reduction in hospitalizations and emergency room visits in patients in a clinical trial as well as a…

Read more…

Go to Source

Exit mobile version